GH-RH antagonists (MIA-602, MIA-604, MIA-690, and JMR-132) block the growth and invasion of glioma cells as well as angiogenesis, upregulate tumor inhibitors, and promote autophagic and apoptotic mechanisms [109,111]. The gene discussed is GHRH; the disease is central nervous system cancer.